 Lung Diseases, Interstitial
"Lung Diseases, Interstitial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Descriptor ID |
D017563
|
| MeSH Number(s) |
C08.381.483
|
| Concept/Terms |
Lung Diseases, Interstitial- Lung Diseases, Interstitial
- Interstitial Lung Disease
- Lung Disease, Interstitial
- Interstitial Lung Diseases
- Diffuse Parenchymal Lung Diseases
Pneumonia, Interstitial- Pneumonia, Interstitial
- Interstitial Pneumonia
- Interstitial Pneumonias
- Pneumonias, Interstitial
- Pneumonitis, Interstitial
- Interstitial Pneumonitides
- Interstitial Pneumonitis
- Pneumonitides, Interstitial
|
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Interstitial".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Interstitial".
This graph shows the total number of publications written about "Lung Diseases, Interstitial" by people in this website by year, and whether "Lung Diseases, Interstitial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 2 | 3 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 5 | 0 | 5 | | 2003 | 3 | 2 | 5 | | 2004 | 4 | 2 | 6 | | 2005 | 6 | 2 | 8 | | 2006 | 8 | 2 | 10 | | 2007 | 8 | 0 | 8 | | 2008 | 5 | 0 | 5 | | 2009 | 12 | 1 | 13 | | 2010 | 8 | 1 | 9 | | 2011 | 6 | 1 | 7 | | 2012 | 12 | 2 | 14 | | 2013 | 18 | 0 | 18 | | 2014 | 12 | 1 | 13 | | 2015 | 11 | 3 | 14 | | 2016 | 14 | 2 | 16 | | 2017 | 19 | 1 | 20 | | 2018 | 13 | 0 | 13 | | 2019 | 25 | 1 | 26 | | 2020 | 18 | 2 | 20 | | 2021 | 21 | 2 | 23 | | 2022 | 30 | 1 | 31 | | 2023 | 35 | 0 | 35 | | 2024 | 31 | 3 | 34 | | 2025 | 20 | 2 | 22 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Diseases, Interstitial" by people in Profiles.
-
Humphries SM, Chung A, Swigris JJ, Oh AS, Walsh SLF, Lynch DA, Goldin JG, Kim GHJ. Quantification of Interstitial Lung Diseases, From the AJR Special Series on Quantitative Imaging. AJR Am J Roentgenol. 2025 Dec; 225(6):e2432053.
-
Bae SS, Markovic D, Saygin D, Sullivan D, Yamaguchi K, Moghadam-Kia S, Oddis CV, Abtin F, Kim GHJ, Marder G, Venuturupalli S, Dellaripa PF, Danoff S, Doyle T, Hunninghake G, Lee JS, Falk J, Johnson C, Goldin J, Tashkin D, Charles-Schoeman C, Aggarwal R. Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI79-SI87.
-
Harris KJR, Ludtke EA, Goldberg B, McCall NN, Hewlett JC, Wilfong EM. Tacrolimus as first-line therapy in a US cohort of idiopathic inflammatory myopathies related interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI179-SI183.
-
Aggarwal R, Pongtarakulpanit N, Sullivan DI, Moghadam-Kia S, Bae SS, Wilkerson J, Saygin D, Marder G, Venuturupalli S, Dellaripa PF, Danoff SK, Doyle T, Hunninghake GM, Lee JS, Fischer A, Falk J, Johnson C, Koontz D, Ascherman DP, Oddis CV. Abatacept for the treatment of myositis-associated interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI156-SI168.
-
Cutting CC, Rose JA, Tukpah AC, Wada N, Nishino M, Kalra S, Moll MR, Cho MH, Silverman EK, Kinney GL, Rossiter HB, Bjarnadottir H, Gudmundsdottir V, Sigurdsson S, Gudmundsson G, Gudnason V, Washko GR, Budoff MJ, Hatabu H, Hunninghake GM, Putman RK. Interstitial lung abnormalities, coronary heart disease and mortality. Eur Respir J. 2025 Nov; 66(5).
-
Kim JS, Pugashetti J, Ma SF, Huang Y, Podolanczuk AJ, Lynch DA, Oh A, Mychaleckyj J, Manichaikul A, Rich S, Chua F, Adams TM, Flaherty KR, Lee JS, Lasky JA, Raghu G, Murray S, Spino C, Martinez FJ, Noth I, Humphries SM, Adegunsoye A, Molyneaux PL, Oldham JM, Newton CA. Associations of interstitial lung disease subtype and CT pattern with lung function and survival. Thorax. 2025 Nov 14; 80(12):927-934.
-
Putman RK, Rose JA, San José Estepar R, Tukpah AC, Cutting CC, Hino T, Hata A, Nishino M, Humphries SM, Lynch DA, Silverman EK, Cho MH, Rosas IO, Washko GR, Hatabu H, San José Estepar R, Hunninghake GM. Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene. Am J Respir Crit Care Med. 2025 Oct; 211(10):1794-1801.
-
Koslow M, Baraghoshi D, Swigris JJ, Brown KK, Fernández Pérez ER, Huie TJ, Keith RC, Mohning MP, Solomon JJ, Yunt ZX, Manco G, Lynch DA, Humphries SM. One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease. Am J Respir Crit Care Med. 2025 Oct; 211(10):1775-1784.
-
Ng N, Molina-Molina M, Adegunsoye A, Borie R, Newton CA, Raby B, Zhang D, Padilla M, Crestani B, Horwitz MS, Keel S, Murray MF, Stergachis AB, Knight S, Garcia CK, Wain LV, Raghu G. Genetics of interstitial lung diseases: a state-of-the-art review. Eur Respir J. 2025 Sep; 66(3).
-
Swigris JJ, Pryor JB, Aronson KI, Guess TA, Solomon JJ. Using Bookmarking to Reveal Dyspnea Severity Categorizations According to Patients with Interstitial Lung Disease and the Physicians Who Treat Them. Ann Am Thorac Soc. 2025 Aug; 22(8):1147-1154.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|